Entry level $8.54 = Target price $9.55 = Stop loss $8.34
Golden cross .
Indicators all bullish.
Buy side dominance in volume.
Reaching the apex of symmetrical triangle
Company profile
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.
Golden cross .
Indicators all bullish.
Buy side dominance in volume.
Reaching the apex of symmetrical triangle
Company profile
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.